EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Artificially Engineered Synthetic Biomarkers Revolutionizing Early Diagnosis of Diseases

Anyun Wang, Min Wei, Keying Yu, Siying Heng, Xinyue Zhao, Wenxi Jian, Jinsong Zhao, Yanfeng Gao iD, Yanping Wang

Molecules · 24.11.2025 · 30 (23) · 4532

DOI: 10.3390/molecules30234532 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 24.11.2025. Verfasst von Anyun Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health, Wannan Medical College, Wuhu 241002, China. Hauptthemen laut MEDLINE: Biomarkers, Neoplasms, Biomarkers, Tumor. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 130 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Anhui Province, Scientific Research Foundation of Education Department of Anhui Province of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Early detection of disease, particularly cancer, is pivotal for improving patient outcomes. However, diagnostic approaches relying on traditional endogenous biomarkers often face significant limitations, primarily due to the low abundance and lack of specificity of these markers, which can lead to delayed or inaccurate diagnosis. Synthetic biomarkers, artificially engineered exogenous agents that are designed to interact with specific biological targets to generate detectable signals, represent a revolutionary approach in diagnostic medicine. By allowing for the conversion and amplification of specific disease-related signals, synthetic biomarkers enable accurate diagnosis, prognosis, and therapy monitoring, holding immense promise for the early detection of diverse disease states to facilitate prompt treatment initiation and to improve clinical outcomes. This review provides a comprehensive overview of the evolution, classification, working mechanisms, and diagnostic applications of synthetic biomarkers, along with a discussion of their future potential in advancing precision medicine and effective disease management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiomarkersNeoplasmsBiomarkers, TumorHumansEarly DiagnosisPrecision MedicineAnimals

Stichwörter der Autor:innen

artificially engineered biomarkerscancerdisease diagnosisexogenous biomarkerspoint-of-care testingprecision medicinesynthetic biology

Substanzen

BiomarkersBiomarkers, Tumor

Autor:innen und Institutionen

  • School of Public Health, Wannan Medical College, Wuhu 241002, China.
  • School of Basic Medical Sciences, Wannan Medical College, Wuhu 241002, China.
  • School of Medical Imaging, Wannan Medical College, Wuhu 241002, China.

ORCID-Profile: Yanfeng Gao

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Anhui Province
  • Scientific Research Foundation of Education Department of Anhui Province of China

Zitieren

APA

Wang, A., Wei, M., Yu, K., Heng, S., Zhao, X., Jian, W., Zhao, J., Gao, Y., & Wang, Y. (2025). Artificially Engineered Synthetic Biomarkers Revolutionizing Early Diagnosis of Diseases. Molecules, 30(23), 4532. https://doi.org/10.3390/molecules30234532

Vancouver

Wang A, Wei M, Yu K, Heng S, Zhao X, Jian W, et al. Artificially Engineered Synthetic Biomarkers Revolutionizing Early Diagnosis of Diseases. Molecules. 2025;30(23):4532. doi:10.3390/molecules30234532

BibTeX
@article{Wang2025,
  author = {Wang, Anyun and Wei, Min and Yu, Keying and Heng, Siying and Zhao, Xinyue and Jian, Wenxi and Zhao, Jinsong and Gao, Yanfeng and Wang, Yanping},
  title = {Artificially Engineered Synthetic Biomarkers Revolutionizing Early Diagnosis of Diseases},
  journal = {Molecules},
  year = {2025},
  volume = {30},
  number = {23},
  pages = {4532},
  doi = {10.3390/molecules30234532}
}
Kostenlos starten →